Trademark: 79293682
Status Date
Thursday, December 14, 2023
Filing Date
Friday, July 10, 2020
Abandoned Date
Thursday, December 14, 2023
5 Pharmaceutical and veterinary products, namely, pharmaceutical products and medications made of peptides for inducing protein aggregation in the treatment of cancer and infectious diseases and synthetic peptides as pharmaceutical products and medications for inducing protein aggregation in the treatment of cancer and infectious diseases; all of the foregoing commercialized through a select network of clinicians who administer the products and medications in a hospital setting or available through prescription by a clinician
42 Scientific and technological services and research and design relating thereto, namely, pharmaceutical research and development of peptide-based pharmaceutical products and medicines and pharmaceutical research and development of pharmaceutical products and medicines on the basis of protein aggregation stimulating peptides
Dec 15, 2023
Abandonment Notice Mailed - After Ex Parte Appeal
Dec 15, 2023
Abandonment Notice Mailed - After Ex Parte Appeal
Dec 14, 2023
Abandonment - After Ex Parte Appeal
Dec 14, 2023
Exparte Appeal Terminated
Oct 30, 2023
Exparte Appeal Dismissed - Failure To File Brief
Aug 16, 2023
Notification Of Action Denying Req For Recon E-Mailed
Aug 16, 2023
Action Denying Req For Recon E-Mailed
Aug 16, 2023
Action Continuing Final - Completed
Nov 18, 2022
Suspension Checked ¿ To Attorney For Action
Apr 2, 2022
New Representative At Ib Received
Apr 1, 2022
Notification Of Letter Of Suspension E-Mailed
Apr 1, 2022
Letter Of Suspension E-Mailed
Apr 1, 2022
Suspension Letter Written
Mar 13, 2022
Notification Of Possible Opposition - Processed By Ib
Feb 23, 2022
Notification Of Possible Opposition Sent To Ib
Feb 23, 2022
Notification Of Possible Opposition Created, To Be Sent To Ib
Jan 26, 2022
Teas/Email Correspondence Entered
Jan 26, 2022
Correspondence Received In Law Office
Jan 26, 2022
Assigned To Lie
Jan 21, 2022
Teas Request For Reconsideration Received
Jan 20, 2022
Ex Parte Appeal-Instituted
Jan 20, 2022
Jurisdiction Restored To Examining Attorney
Jan 20, 2022
Exparte Appeal Received At Ttab
Jul 30, 2021
Notification Of Final Refusal Emailed
Jul 30, 2021
Final Refusal E-Mailed
Jul 30, 2021
Final Refusal Written
Jul 4, 2021
Assigned To Examiner
Apr 26, 2021
Teas/Email Correspondence Entered
Apr 26, 2021
Correspondence Received In Law Office
Apr 26, 2021
Teas Response To Office Action Received
Apr 2, 2021
New Representative At Ib Received
Dec 6, 2020
Refusal Processed By Ib
Nov 13, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Nov 13, 2020
Refusal Processed By Mpu
Oct 27, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Oct 26, 2020
Non-Final Action Written
Oct 22, 2020
Assigned To Examiner
Sep 29, 2020
Application Filing Receipt Mailed
Sep 25, 2020
New Application Office Supplied Data Entered
Sep 22, 2020
Limitation From Original Application Entered
Sep 17, 2020
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
